Immunitor Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Immunitor General Information

Description

Developer of vaccines. The company i9s engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, and bacterial and fungal infections.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Acquirer
Immune Network
Primary Office
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunitor‘s full profile, request access.

Request a free trial

Immunitor Executive Team (1)

Name Title Board Seat Contact Info
Aldar Bourinbaiar Chief Executive Officer & Principal
To view Immunitor’s complete executive team members history, request access »